William Blair Investment Management, LLC Amicus Therapeutics, Inc. Transaction History

William Blair Investment Management, LLC

$32.7 Billion
Q1 2025

A detailed history of William Blair Investment Management, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, William Blair Investment Management, LLC holds 14,778,651 shares of FOLD stock, worth $93 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

14,778,651

Previous 15,597,698 5.25%

Holding current value

$93 Million

Previous $147 Million 17.92%

% of portfolio

0.37%

Previous 0.38%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$8.16 - $9.85 $6.68 Million - $8.07 Million	-819,047 Reduced 5.25%	14,778,651 $121 Million
Q4 2024 Feb 10, 2025	BUY	$9.36 - $12.01 $137,928 - $176,979	14,736 Added 0.09%	15,597,698 $147 Million
Q3 2024 Nov 08, 2024	BUY	$9.55 - $12.09 $24.6 Million - $31.2 Million	2,579,599 Added 19.84%	15,582,962 $166 Million
Q2 2024 Aug 08, 2024	BUY	$9.04 - $11.75 $13.4 Million - $17.4 Million	1,477,084 Added 12.81%	13,003,363 $129 Million
Q1 2024 May 08, 2024	SELL	$11.43 - $14.24 $1.38 Million - $1.72 Million	-120,747 Reduced 1.04%	11,526,279 $136 Million
Q4 2023 Feb 09, 2024	BUY	$9.97 - $14.52 $12.7 Million - $18.4 Million	1,270,263 Added 12.24%	11,647,026 $165 Million
Q3 2023 Nov 09, 2023	BUY	$11.78 - $13.86 $95.1 Million - $112 Million	8,070,098 Added 349.86%	10,376,763 $126 Million
Q2 2023 Aug 10, 2023	BUY	$10.72 - $13.3 $274,142 - $340,120	25,573 Added 1.12%	2,306,665 $29 Million
Q1 2023 May 12, 2023	BUY	$10.91 - $13.54 $1.96 Million - $2.44 Million	179,906 Added 8.56%	2,281,092 $25.3 Million
Q4 2022 Feb 09, 2023	BUY	$9.89 - $12.7 $156,479 - $200,939	15,822 Added 0.76%	2,101,186 $25.7 Million
Q3 2022 Nov 09, 2022	SELL	$9.82 - $12.75 $4.54 Million - $5.89 Million	-462,242 Reduced 18.14%	2,085,364 $21.8 Million
Q2 2022 Aug 10, 2022	BUY	$6.23 - $11.12 $100,888 - $180,077	16,194 Added 0.64%	2,547,606 $27.4 Million
Q1 2022 May 11, 2022	BUY	$7.89 - $12.48 $431,511 - $682,543	54,691 Added 2.21%	2,531,412 $24 Million
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $4.93 Million - $6.24 Million	501,749 Added 25.41%	2,476,721 $28.6 Million
Q3 2021 Nov 10, 2021	BUY	$8.74 - $11.84 $203,598 - $275,812	23,295 Added 1.19%	1,974,972 $18.9 Million
Q2 2021 Aug 12, 2021	BUY	$8.71 - $10.72 $6.89 Million - $8.48 Million	790,953 Added 68.14%	1,951,677 $18.8 Million
Q1 2021 May 13, 2021	BUY	$9.2 - $23.86 $819,471 - $2.13 Million	89,073 Added 8.31%	1,160,724 $11.5 Million
Q4 2020 Feb 09, 2021	BUY	$13.47 - $24.89 $1.43 Million - $2.64 Million	105,888 Added 10.96%	1,071,651 $24.7 Million
Q3 2020 Nov 06, 2020	BUY	$12.89 - $15.89 $12.4 Million - $15.3 Million	965,763 New	965,763 $13.6 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

322M

Call Options Held

378K

Put Options Held

575K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $1.76B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on William Blair Investment Management, LLC with notifications on news.

Account

William Blair Investment Management, LLC Amicus Therapeutics, Inc. Transaction History